课题基金 / 基金详情

Epigenetics of Aging and Age-associated Diseases

Epigenetics of Aging and Age-associated Diseases
衰老和年龄相关疾病的表观遗传学
批准号:
8609442
负责人:
SHELLEY L BERGER
金额:
$179.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-15 至 2018-06-30

项目摘要

项目成果

SHELLEY L BERGER的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Epigenetics is defined as heritable changes in genomic function and phenotype that do not involve alteration to DNA sequence. This higher level control of genome function is embodied in chromatin, a composite of nucleosomes (DNA and histones), as well as other non-histone proteins. Human disease is increasingly being linked to epigenetic and chromatin changes. The central hypothesis of this Program Project is that chromatin, as an inherently dynamic structure, is prone to age-associated degeneration, but that this degeneration is also countered by protective processes. This Program Project studies these age-associated chcomatin changes as they occur in the context of cell senescence, an irreversible proliferation arrest of damaged cells that contributes to tissue aging. Our studies from the first cycle of funding confirmed the previously suspected role for epigenetics as a critical determinant of aging and longevity. As a cross-disciplinary and highly collaborative team (46 manuscripts to date [published or submitted] in the 2008-2013 funding cycle, of which 19 are collaborative), we will continue to employ biochemistry, structural biology, cell biology, yeas genetics, and state-of-the-art epigenomic technologies in yeast and human cells to elucidate the role of epigenetics in aging and senescence. In particular, we will define degenerative and protective changes to chromatin, and the molecular mechanisms underlying them. The relevance of these studies for aging will be tested by reference to young and old human tissues and in mouse models, assessing phenotypes of aging. Moreover, based on our findings from the first cycle of funding, we have already initiated efforts to leverage our mechanistic insights into lead compounds for novel therapies to promote healthy aging. Our ultimate goal is to understand the balance of processes that culminate in age-associated chromatin dysfunction, so that we can devise strategies to manipulate the balance to promote healthy aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The metabolic-epigenetic axis in memory
  • 批准号:
    10196896
  • 项目类别:
  • 资助金额:
    $44.89万
  • 财政年份:
    2019
  • 负责人:
    SHELLEY L BERGER
  • 依托单位:
The metabolic-epigenetic axis in memory
  • 批准号:
    9764788
  • 项目类别:
  • 资助金额:
    $44.73万
  • 财政年份:
    2019
  • 负责人:
    SHELLEY L BERGER
  • 依托单位:
The metabolic-epigenetic axis in memory
  • 批准号:
    10399581
  • 项目类别:
  • 资助金额:
    $44.91万
  • 财政年份:
    2019
  • 负责人:
    SHELLEY L BERGER
  • 依托单位:
The metabolic-epigenetic axis in memory
  • 批准号:
    10617251
  • 项目类别:
  • 资助金额:
    $44.91万
  • 财政年份:
    2019
  • 负责人:
    SHELLEY L BERGER
  • 依托单位: